A new report says the withdrawal of U.S. funding has caused a “systemic shock” to the global effort against AIDS and HIV.

In an interview with The News & Observer, Dr. Barton Haynes discusses the future of HIV vaccine development after HHS ...

In a report released on Thursday, the UN body in charge of fighting HIV/Aids does not single out the US, but says that ...

Gilead Sciences and the Global Fund to Fight AIDS, Tuberculosis and Malaria said on Wednesday they had finalized plans to ...

The HIV pandemic still claims a life every minute. While progress has been made, there were 1.3 million new HIV infections ...

Gilead announced a deal to get its groundbreaking HIV prevention drug to lower income countries. Notably, the deal does not ...

Gilead Sciences (GILD) stock in focus as the company joins The Global Fund to expand access to lenacapavir, an HIV PrEP ...

A historic funding crisis is threatening to unravel decades of progress unless countries can make radical shifts to HIV programming and funding. The report highlights the impact that the sudden, large ...

UNAIDS emphasizes that every dollar invested in the HIV response not only saves lives but strengthens health systems and promotes broader development goals. Since the start of the epidemic, 26.9 ...

Merck on Thursday said the application covers the investigational, once-daily, oral two-drug regimen for adults with HIV-1 infection that is virologically suppressed on antiretroviral therapy. The ...

Health Minister Aaron Motsoaledi assures that South Africa’s HIV/AIDS programme will continue, with R753 million from Treasury and R600 million in global funding replacing lost US support.

More than $50 million in grants for HIV, sexually transmitted infections, and hepatitis programs could disappear under a proposed federal budget.